High fat diet-induced changes in hepatic protein abundance in mice

Journal of Proteomics and Bioinformatics

Volumn 5, Issue 3, 2012, Pages 60-66

  Luo, Moulun ^a   Mengos, April E ^a   Stubblefield, Tianna M ^a   Mandarino, Lawrence J ^a  

^a MAYO CLINIC   (United States)

Author keywords

C57BL 6J; High fat diet; Insulin resistance; Mass spectrometry; NAFLD

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; AMINO PEPTIDASE N; APOLIPOPROTEIN A1; ATP CITRATE SYNTHASE; CARBAMOYL PHOSPHATE SYNTHASE; CARBOXYLESTERASE 1; FAS ANTIGEN; FATTY ACID SYNTHASE; FATTY ALDEHYDE DEHYDROGENASE; GLUCOSE; INSULIN; KETOHEXOKINASE; KIAA0564 PROTEIN; KIAA0664 PROTEIN; LIVER PROTEIN; LONG CHAIN FATTY ACID COA LIGASE 5; MALATE DEHYDROGENASE (NADP); MULTIDRUG RESISTANCE PROTEIN 2; ORNITHINE OXOACID AMINOTRANSFERASE; PYRUVATE KINASE ISOENZYME L; PYRUVATE KINASE ISOENZYME R; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FUNCTIONAL PROTEOMICS; IMMUNOBLOTTING; INFLAMMATION; INFUSION RATE; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; MALE; MOLECULAR PATHOLOGY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TANDEM MASS SPECTROMETRY; UPREGULATION;

MUS;

EID: 84859327452     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.1000214     Document Type: Article

References (30)

1. Angulo P (2002) Nonalcoholic Fatty Liver Disease. N Engl J Med 346: 1221-1231.
2. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, et al. (2005) Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54: 603-608.
3. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, et al. (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109: 1345-1350.
4. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, et al. (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168: 1609-1616.
5. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, et al. (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 106: 15430-15435.
6. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793-1801.
7. De Taeye BM, Novitskaya T, McGuinness OP, Gleaves L, Medda M, et al. (2007) Macrophage TNF-alpha contributes to insulin resistance and hepatic steatosis in diet-induced obesity. Am J Physiol Endocrinol Metab 293: E713-725.
8. Samuel VT, Petersen KF, Shulman GI (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375: 2267-2277.
9. Sundaresan S, Vijayagopal P, Mills N, Imrhan V, Prasad C (2011) A mouse model for nonalcoholic steatohepatitis. J Nutr Biochem 22: 979-984.
10. Kim S, Sohn I, Ahn JI, Lee KH, Lee YS (2004) Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 340: 99-109.
11. Capel F, Delmotte MH, Brun M, Lonchampt M, De Fanti B, et al. (2011) Aging and obesity induce distinct gene expression adaptation in the liver of C57BL/6J Mice. J Nutrigenet Nutrigenomics 4: 154-164.
12. Do GM, Kwon EY, Kim E, Kim HS, Choi MS (2010) Hepatic transcription response to high-fat treatment in mice: microarray comparison of individual vs. pooled RNA samples. Biotechnol J 5: 970-973.
13. Luo M, Langlais P, Yi Z, Lefort N, De Filippis EA, et al. (2007) Phosphorylation of human insulin receptor substrate-1 at Serine 629 plays a positive role in insulin signaling. Endocrinology 148: 4895-4905.
14. Yi Z, Luo M, Mandarino LJ, Reyna SM, Carroll CA, et al. (2006) Quantification of phosphorylation of insulin receptor substrate-1 by HPLC-ESI-MS/MS. J Am Soc Mass Spectrom 17: 562-567.
15. Hwang H, Bowen BP, Lefort N, Flynn CR, De Filippis EA, et al. (2010) Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 59: 33-42.
16. Cheung O, Sanyal AJ (2010) Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol 26: 202-208.
17. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438.
18. de Meijer VE, Le HD, Meisel JA, Akhavan Sharif MR, Pan A, et al. (2010) Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. Metabolism 59: 1092-1105.
19. Kirpich IA, Gobejishvili LN, Bon Homme M, Waigel S, Cave M, et al. (2011) Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. J Nutr Biochem 22: 38-45.
20. Kim JH, Pan JH, Park HG, Yoon HG, Kwon OJ, et al. (2010) Functional Comparison of Esterified and Free Forms of Conjugated Linoleic Acid in High-Fat-Diet-Induced Obese C57BL/6J Mice. J Agric Food Chem.
21. Jiang L, Wang Q, Yu Y, Zhao F, Huang P, et al. (2009) Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway. PLoS One 4: e6884.
22. Zhang L, Perdomo G, Kim DH, Qu S, Ringquist S, et al. (2008) Proteomic analysis of fructose-induced fatty liver in hamsters. Metabolism 57: 1115-1124.
23. Zhou Y, Jiang L, Rui L (2009) Identification of MUP1 as a regulator for glucose and lipid metabolism in mice. J Biol Chem 284: 11152-11159.
24. Hui X, Zhu W, Wang Y, Lam KS, Zhang J, et al. (2009) Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice. J Biol Chem 284: 14050-14057.
25. Martinez AI, Perez-Arellano I, Pekkala S, Barcelona B, Cervera J (2010) Genetic, structural and biochemical basis of carbamoyl phosphate synthetase 1 deficiency. Mol Genet Metab 101: 311-323.
26. Seiler N (2000) Ornithine aminotransferase, a potential target for the treatment of hyperammonemias. Curr Drug Targets 1: 119-153.
27. Mina-Osorio P (2008) The moonlighting enzyme CD13: old and new functions to target. Trends Mol Med 14: 361-371.
28. Wickstrom M, Larsson R, Nygren P, Gullbo J (2011) Aminopeptidase N (CD13) as a target for cancer chemotherapy. Cancer Sci 102: 501-508.
29. Demozay D, Rocchi S, Mas JC, Grillo S, Pirola L, et al. (2004) Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin. J Biol Chem 279: 6261-6270.
30. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action and type 2 diabetes. Science 306: 457-461.